Opus Genetics (R3X1) Ratios
Opus Genetics Ratios
DE:R3X1's free cash flow for Q2 2026 was $-11.95M. For the 2026 fiscal year, DE:R3X1's free cash flow was increased by $0.00 and operating cash flow was $-11.95M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 |
| Quick Ratio | 6.43 | 3.24 | 13.35 | 17.79 | 6.76 |
| Cash Ratio | 5.80 | 2.68 | 12.49 | 15.49 | 6.36 |
| Solvency Ratio | -1.42 | -1.91 | -2.47 | 6.50 | -14.71 |
| Operating Cash Flow Ratio | -4.53 | -2.26 | -0.28 | 5.20 | -5.02 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | -36.00 |
| Net Current Asset Value | $ 15.15M | $ 6.47M | $ 49.91M | $ 46.23M | $ 22.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 3.27 | 5.48 | 1.08 | 1.06 | 1.17 |
| Debt Service Coverage Ratio | -32.79 | 0.00 | -7.52 | 1989.00 | -104.98 |
| Interest Coverage Ratio | -26.33 | 0.00 | -7.95 | 2025.11 | -11352.50 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.06 | 0.00 | 0.04 |
| Net Debt to EBITDA | 0.94 | 0.53 | 5.07 | -2.34 | 0.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -339.00% | -523.40% | -52.36% | 45.70% | -9624.96% |
| EBITDA Margin | -338.63% | -523.31% | -52.33% | 45.71% | -9624.28% |
| Operating Profit Margin | -271.90% | -564.72% | -55.45% | 45.74% | -3854.84% |
| Pretax Profit Margin | -349.33% | -523.40% | -52.36% | 45.68% | -9625.30% |
| Net Profit Margin | -349.33% | -523.40% | -52.42% | 44.89% | -9625.30% |
| Continuous Operations Profit Margin | -349.33% | -523.40% | -52.42% | 44.89% | -9625.30% |
| Net Income Per EBT | 100.00% | 100.00% | 100.12% | 98.27% | 100.00% |
| EBT Per EBIT | 128.48% | 92.68% | 94.42% | 99.87% | 249.69% |
| Return on Assets (ROA) | -98.70% | -156.07% | -18.51% | 36.51% | -217.41% |
| Return on Equity (ROE) | -323.11% | -855.62% | -20.01% | 38.69% | -255.12% |
| Return on Capital Employed (ROCE) | -90.90% | -242.79% | -21.17% | 39.42% | -102.17% |
| Return on Invested Capital (ROIC) | -90.90% | -242.79% | -21.17% | 38.73% | -99.76% |
| Return on Tangible Assets | -98.70% | -156.07% | -18.51% | 36.51% | -217.41% |
| Earnings Yield | -3.97% | -180.97% | -35.86% | 69.57% | -295.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.49 | 1.90 | 8.17 | 8.22 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 71.34 | 43.62 | 0.00 | 6641.67 | 58.90 |
| Asset Turnover | 0.28 | 0.30 | 0.35 | 0.81 | 0.02 |
| Working Capital Turnover Ratio | 0.42 | 0.29 | 0.40 | 1.16 | 0.03 |
| Cash Conversion Cycle | 81.38 | 191.66 | 44.70 | 44.42 | 0.00 |
| Days of Sales Outstanding | 81.38 | 191.66 | 44.70 | 44.42 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 81.38 | 191.66 | 44.70 | 44.42 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | -0.96 | -0.05 | 0.72 | -1.30 |
| Free Cash Flow Per Share | -0.06 | -0.96 | -0.05 | 0.72 | -1.30 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -36.00 |
| Operating Cash Flow to Sales Ratio | -2.48 | -2.33 | -0.06 | 0.36 | -32.89 |
| Free Cash Flow Yield | -2.82% | -80.45% | -3.99% | 55.67% | -101.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.51 | -0.55 | -2.79 | 1.44 | -0.34 |
| Price-to-Sales (P/S) Ratio | 88.10 | 2.89 | 1.46 | 0.65 | 32.53 |
| Price-to-Book (P/B) Ratio | 81.49 | 4.73 | 0.56 | 0.56 | 0.86 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -35.48 | -1.24 | -25.05 | 1.80 | -0.99 |
| Price-to-Operating Cash Flow Ratio | -35.48 | -1.24 | -25.05 | 1.80 | -0.99 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | -0.00 | 0.02 | -0.01 | 0.01 |
| Enterprise Value Multiple | -25.08 | -0.03 | 2.27 | -0.93 | 0.09 |
| Enterprise Value | 1.21B | 1.47M | -22.65M | -16.92M | -4.84M |
| EV to EBITDA | -25.08 | -0.03 | 2.27 | -0.93 | 0.09 |
| EV to Sales | 84.92 | 0.13 | -1.19 | -0.42 | -8.21 |
| EV to Free Cash Flow | -34.20 | -0.06 | 20.37 | -1.18 | 0.25 |
| EV to Operating Cash Flow | -34.20 | -0.06 | 20.37 | -1.18 | 0.25 |
| Tangible Book Value Per Share | 0.02 | 0.25 | 2.31 | 2.32 | 1.50 |
| Shareholders’ Equity Per Share | 0.02 | 0.25 | 2.31 | 2.32 | 1.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | -0.00 | 0.02 | 0.00 |
| Revenue Per Share | 0.02 | 0.41 | 0.88 | 2.00 | 0.04 |
| Net Income Per Share | -0.08 | -2.15 | -0.46 | 0.90 | -3.82 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.98 | 1.00 |
| Interest Burden | 1.03 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 2.17 | 2.44 | 0.93 | 0.36 | 25.76 |
| SG&A to Revenue | 1.55 | 1.66 | 0.63 | 0.18 | 13.79 |
| Stock-Based Compensation to Revenue | 0.24 | 0.31 | 0.18 | 0.05 | 3.25 |
| Income Quality | 0.71 | 0.44 | 0.11 | 0.80 | 0.34 |
Currency in USD
